Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Tim Barabe, Lewis Shuster

Premium

Former Affymetrix CFO Tim Barabe has joined the board of directors of Opexa Therapeutics, a Woodlands, Texas-based biotechnology company.

Barabe retired from his role as CFO and executive vice president last year. Before joining the microarray vendor, he was also CFO of Human Genome Sciences and Regent Medical Ltd.

Barabe also serves on the board of ArQule, a Boston-based biotech company, Opexa said.


HTG Molecular Diagnostics has appointed Lewis Shuster to its board of directors.

Shuster is CEO of Shuster Capital, a strategic and operating advisory firm to life science company executives and investors based in Encinitas, Calif. He served previously as president of Invitrogen's Genomics division, CEO of Kemia, as well as CFO of Human Genome Sciences and Pharmacopeia.

He is currently a board member with Response Biomedical, Mast Therapeutics, Cleave Biosciences and MSN Healthcare.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.